Expired Tender USA ICB TOT Ref. 140842701

New Generation Of Glucose Control Technologies Tender - 140842701

Tender notice from USA, published on 08 May 2026.

Executive Summary

The NATIONAL INSTITUTES OF HEALTH has issued a Tender notice for the procurement of a New Generation Of Glucose Control Technologies Incorporating Ai/Ml Tools/Strategies (R01 - Clinical Trial Optional) in the USA. This Tender notice was published on 08 May 2026 and is scheduled to close on 17 Jun 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 140842701, while the tender notice number is RFA-DK-27-146 and Register on the platform.

Key facts

Summary
New Generation Of Glucose Control Technologies Incorporating Ai/Ml Tools/Strategies (R01 - Clinical Trial Optional)
TOT Ref. No.
140842701
Document Ref. No.
RFA-DK-27-146
Country
USA
Notice type
Tender
Competition
ICB
Publication date
08 May 2026
Bid deadline
17 Jun 2026
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
Public
Financier
Self Financed

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

The Purpose Of This Funding Opportunity Is To Support Research Addressing Barriers That Limit Progress Toward More Effective Open- And Closed-Loop Diabetes Control Systems. This May Include Research That Addresses: 1) Innovation Of Sensing Relevant Analytes/Physiologic Signals; 2) Novel Formulation And Delivery Of Hormones; 3) Artificial Intelligence (Ai)/Machine Learning (Ml)-Driven Tools/Algorithms; And 4) Digital Twin Modeling To Augment Decision Support And Automated Control Systems With The Goal Of Improving Glycemic Control, Reducing Burden Of Care, And Enhancing Quality Of Life Of People... With T1D].This Nofo Is Associated With The Special Diabetes Program (Https://Www.Niddk.Nih.Gov/About-Niddk/Research-Areas/Diabetes/Type-1-Diabetes-Special-Statutory-Funding-Program/About-Special-Diabetes-Program) Which Funds Research On The Prevention, Treatment, And Cure Of Type 1 Diabetes And Its Complications, Including Unique, Innovative, And Collaborative Research Consortia And Clinical Trials Networkseligibilityeligible Applicantsgovernmentpublic And Indian Housing Authoritiesfederally Recognized Native American Tribal Governmentsstate Governmentscity Or Township Governmentsspecial District Governmentscounty Governmentsbusinesssmall Businessesfor-Profit Organizations Other Than Small Businessesnonprofitother Native American Tribal Organizationsnonprofits Non-Higher Education Without 501(C)(3)Nonprofits Non-Higher Education With 501(C)(3)Educationpublic And State Institutions O...
Award max: $500, 000

Posted Date: 2026-05-07 00:00:00

Funding instrument type: Grant

Documents

Tender Notice
Login to view

USA Public Procurement Intelligence

Frequently asked questions

The bid deadline for New Generation Of Glucose Control Technologies Incorporating Ai/Ml Tools/Strategies (R01 - Clinical Trial Optional) was 17 Jun 2026. Bidding is closed.

This tender has been issued by NATIONAL INSTITUTES OF HEALTH in USA.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 140842701. The purchaser document reference is RFA-DK-27-146.

Browse other tenders from USA or search by relevant keywords and CPV classification.